CLUSTER filed May 10, 2026 at 20:00 ET
A cluster of insider sales at ANI Pharmaceuticals, led by CEO Nikhil Lalwani selling $4.27M worth of shares, follows a strong Q1 2026 earnings beat and raised guidance. The total insider selling of ~$5.7M over the cluster window represents about 0.3% of market cap, which is modest but notable given the CEO's participation. The sales are likely liquidity-driven after a significant stock run-up post-earnings, but the cluster's timing and size warrant monitoring for any upcoming negative catalysts.